The paucity of data in this research area suggests that, despite the recognized link between thyroid hormones and metabolic diseases, the specific mechanisms by which thyroid hormone levels affect the risk of MASLD in patients remain unclear. The gene discussed is TG; the disease is metabolic dysfunction-associated steatotic liver disease.